C. H. Robinson Worldwide
CHRW
$133.76
+3.70%
C.H. Robinson Worldwide is the largest non-asset-based third-party logistics provider in North America, operating a vast truckload and LTL brokerage network alongside a sizable air and ocean forwarding franchise, with domestic freight brokerage representing roughly 64% of net revenue and global forwarding about 26%. Its competitive identity rests on scale — a network of over 100,000 contracted carriers, proprietary pricing technology, and a data moat that lets it match shipper demand to carrier capacity more efficiently than asset-heavy peers like FedEx or UPS. The current investor narrative is a tug-of-war between genuine operational improvement and structural fear: Q3 2026 results beat estimates on pricing discipline and 'Lean AI' productivity gains, and management has driven gross margins sharply higher, yet the stock has been punished amid worries that Amazon's aggressive push into third-party logistics could commoditize brokerage, compounded by a soft freight cycle and a sharp post-earnings selloff. The debate now centers on whether CHRW's margin expansion and AI-driven cost takeout are durable enough to offset volume pressure and competitive disruption.…
CHRW
C. H. Robinson Worldwide
$133.76
Related headlines
Investment Opinion: Should I buy CHRW Today?
Rating: Hold with a constructive, accumulation-biased tilt. The core thesis is that CHRW's operational improvement is real — Q3 2026 gross profit rose to $808.4 million from $738.0 million in Q2, lifting gross margin to 15.1% while revenue grew 29.5% YoY to $5.358 billion — but the stock is in a confirmed downtrend at $125.33, just 1.6% above its $122.21 52-week low, and the market is not yet willing to pay for the recovery. The 18 Buy / 5 Hold / 0 Sell consensus and $179.30 average target (43% upside) anchor a favorable risk/reward, but the stock trading below every published target (low $131.00) warns that estimates may still be catching down to reality.
Supporting evidence is genuinely mixed but skews favorably on forward numbers. The forward PE of 16.8x versus 32.9x trailing implies roughly 49% multiple compression as consensus EPS of $7.96 replaces the depressed trailing figure, and the PEG of 1.29 suggests that growth is reasonably priced. Profitability is strong for a thin-margin broker: TTM ROE of 31.8% and ROA of 10.3% on a capital-light, 100,000-plus carrier network, with operating margin holding near 5.1% and net margin at 3.7%. On sales-based measures the stock looks cheap — PS of 1.19x and EV/Sales of 0.905x against 29.5% revenue growth — but EV/EBITDA of 23.4x and P/B of 10.5x are elevated, and TTM FCF of $505.9 million is lumpy ($106.6M in Q3, $30.9M in Q2, $66.0M in Q1) after $136.9 million of Q3 working-capital absorption.
The biggest risks that could invalidate the thesis are (1) a failure of Q4 gross margin to hold above 15%, which would break the margin-expansion narrative; (2) Amazon's 3PL push commoditizing the ~64%-of-revenue domestic brokerage franchise; and (3) further downward analyst target revisions given the 79%-of-price spread between the $131 low and $235 high. This Hold would upgrade to Buy on a decisive reclaim of the $157-$160 October breakdown zone accompanied by gross margin above 15% and stabilizing volumes, or if the forward PE compresses below ~14x on unchanged EPS estimates; it would downgrade to Sell on a break below $122.21 with gross margin slipping under 14.5%. Verdict: fairly valued to modestly undervalued on forward earnings, but expensive on trailing and book measures — a recovery bet, not a deep-value entry.
Sign up to view all
CHRW 12-Month Price Forecast
CHRW presents a genuine tug-of-war: the operating story is improving — 15.1% gross margin, 31.8% ROE, and 29.5% revenue growth — while the tape is capitulating at $125.33, just above the 52-week low, with a -40.5% max drawdown and a -25.0% one-year relative strength gap versus the S&P 500. The forward PE of 16.8x against 32.9x trailing means the market is being asked to pay a rich multiple on trough earnings for a far cheaper one on recovery profits, and the PEG of 1.29 suggests that bet is reasonably priced if $7.96 EPS is delivered. The bear case has stronger near-term evidence — lumpy quarterly FCF ($30.9M in Q2, $106.6M in Q3), thin 3.7% net margin, and Amazon's $1.3 trillion 3PL ambition against a ~64%-brokerage revenue base — which is why the stance is neutral rather than bullish despite the 43% target upside. I would upgrade to bullish on a reclaim of the $157-$160 breakdown zone with gross margin above 15% and stabilizing volumes, and downgrade to bearish on a break below $122.21 with gross margin slipping under 14.5%. Until one of those resolves, the risk/reward is asymmetric but the timing is uncertain.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on C. H. Robinson Worldwide's 12-month outlook, with a consensus price target around $179.30 and implied upside of +34.0% versus the current price.
Average Target
$179.30
23 analysts
Implied Upside
+34.0%
vs. current price
Analyst Count
23
covering this stock
Price Range
$131 - $235
Analyst target range
Coverage is broad and overwhelmingly constructive: 23 analysts cover CHRW with 18 Buy ratings, 5 Hold, and 0 Sell, yielding a consensus recommendation of 'buy' (mean score 1.61 on a 1-5 scale where 1 is Strong Buy). The average target price of $179.30 implies roughly +43% upside from the current $125.33 — an unusually large gap that signals either significant undervaluation or stale targets that have not yet been marked down to reflect the recent collapse. Recent actions skew positive but static: Susquehanna reiterated Positive on November 2, and on October 29 Stifel, Citigroup, JP Morgan, Truist, Stephens, UBS, and Wells Fargo all maintained Buy/Overweight ratings, with only TD Cowen (Hold) and BMO (Market Perform) sitting on the sidelines — notably, no firm has downgraded despite the stock's 40% drawdown.
The target range is extremely wide, from a low of $131.00 (just 4.5% above the current price) to a high of $235.00 (87.5% above), a spread of roughly 79% of the current price that signals high uncertainty and divergent views on the freight-cycle recovery. The high target likely assumes multiple expansion back toward historical norms plus delivery on the $7.96 consensus EPS estimate and AI-driven margin gains, while the low target of $131 essentially prices in continued volume pressure and margin compression with little recovery. The fact that even the low target sits above the current price suggests analysts view the selloff as overdone, but the wide dispersion and the stock trading below every published target warn that consensus estimates may still be catching up to reality — a setup where the risk of further downward target revisions is real until price action stabilizes.
Bulls vs Bears: CHRW Investment Factors
The bear case currently has stronger near-term evidence: CHRW sits 1.6% above its 52-week low after a -40.5% max drawdown, underperforms the S&P 500 by 25 percentage points over one year, and faces a credible structural threat from Amazon's 3PL ambitions against a brokerage business that is roughly 64% of net revenue. The bull case rests on genuine operational improvement — 15.1% gross margin, 31.8% ROE, 29.5% revenue growth, and a forward PE of 16.8x versus 32.9x trailing — plus a unanimous no-Sell analyst consensus with a $179.30 average target implying 43% upside. The single most important tension is whether margin expansion and AI-driven cost takeout are durable enough to offset volume pressure and competitive disruption; if Q4 gross margins hold above 15% and volumes stabilize, the 43% target gap closes, but a break below $122.21 would validate the structural-fear thesis.
Bullish
- Analyst consensus overwhelmingly Buy with 43% upside: All 23 covering analysts rate CHRW Buy or Hold with zero Sells, and the $179.30 average target sits 43% above the $125.33 price. Even the lowest published target of $131.00 is 4.5% above the current quote, implying the Street views the selloff as overdone rather than fundamentally justified.
- Gross margin expansion despite revenue surge: Q3 2026 gross profit rose to $808.4 million from $738.0 million in Q2, lifting gross margin to 15.1% from 15.0% sequentially even as revenue jumped 29.5% YoY to $5.358 billion. Pricing discipline and 'Lean AI' SG&A leverage are visibly offsetting purchased-transportation inflation.
- Forward PE of 16.8x versus 32.9x trailing: The 49% trailing-to-forward multiple compression reflects consensus EPS of $7.96 versus the depressed trailing figure, meaning investors pay a rich multiple on trough earnings for a far cheaper one on recovery profits. The PEG of 1.29 suggests that forward growth is reasonably priced.
- Strong returns on capital from asset-light model: TTM ROE of 31.8% and ROA of 10.3% are exceptional for a thin-margin brokerage, supported by a capital-light structure and a network of over 100,000 contracted carriers. These returns underpin the 10.5x P/B and explain why book value understates earning power.
Bearish
- Stock at 52-week low, down 40.5% from peak: At $125.33, CHRW trades just 1.6% above its 52-week low of $122.21 and 40.4% below its $210.33 high, with a max drawdown of -40.5% confirming a full bear phase. The stock is down 26.9% over six months and 23.4% YTD versus the S&P 500's +9.6% one-year return, a -25.0% relative strength gap.
- Amazon 3PL entry threatens brokerage commoditization: Amazon's aggressive push into third-party logistics — framed as a $1.3 trillion TAM opportunity mirroring its AWS playbook — poses a structural threat to traditional freight brokers. With domestic brokerage at roughly 64% of net revenue, CHRW is directly exposed to pricing pressure if Amazon commoditizes the matching function.
- Lumpy, weak quarterly free cash flow: TTM FCF of $505.9 million masks a weak quarterly pattern: just $106.6 million in Q3, $30.9 million in Q2, and $66.0 million in Q1, as working capital absorbed $136.9 million in Q3 alone. Aggressive buybacks and dividends funded partly by cash draws leave limited internal cushion if freight deteriorates.
- Revenue growth quality is questionable: The 29.5% YoY revenue growth to $5.358 billion contrasts with a -15.4% one-year stock decline, implying the market discounts the growth as purchased-transportation cost pass-through rather than margin-accretive volume. Net margin of 3.7% and operating margin of 5.1% remain thin, leaving little buffer.
CHRW Technical Analysis
The prevailing trend is decisively negative: CHRW is down 15.4% over the past year and 23.4% year-to-date, a stark underperformance versus the S&P 500's +9.6% one-year return, translating to a relative strength gap of -25.0% over twelve months. At $125.33, the stock sits just 1.6% above its 52-week low of $122.21 and a staggering 40.4% below its 52-week high of $210.33 — effectively trading at the very bottom of its range, which signals capitulation-style selling rather than a healthy pullback and raises the risk of a 'falling knife' for momentum buyers. The maximum drawdown of -40.5% confirms a full-blown bear phase rather than a garden-variety correction.
Short-term momentum is uniformly weak and accelerating to the downside: the stock is down 7.3% over one month, 16.1% over three months, and 26.9% over six months, with each successive window confirming rather than contradicting the longer-term downtrend. The 1-month relative strength of -2.3% versus SPY's -5.0% shows CHRW is underperforming even a weak tape, and the recent sequence — a collapse from $205.51 on July 23 to $146.92 by July 30, a partial recovery to $157.72 in early October, then a fresh leg down to $125.33 — reveals a pattern of lower highs and lower lows with no base formation. The most recent session's -2.3% decline on above-average volume of roughly 1.14 million shares suggests sellers remain in control and no capitulation-volume reversal has yet materialized.
Key technical levels are tightly defined: support sits at the 52-week low of $122.21, just 2.5% below the current $125.33, while resistance is anchored at the $210.33 high with intermediate supply near $157-$160 (the October breakdown zone). A decisive break below $122.21 would likely trigger stop-loss cascades and open the door to new lows, whereas reclaiming $157 would be the first meaningful sign of trend repair. With a beta of 0.947, CHRW is slightly less volatile than the market on paper, but its -40.5% max drawdown demonstrates that idiosyncratic freight-cycle and competitive risk dominate its risk profile — position sizing should account for gap risk around earnings rather than relying on beta alone.
Beta
0.95
0.95x market volatility
Max Drawdown
-40.5%
Largest decline past year
52-Week Range
$122-$210
Price range past year
Annual Return
-11.2%
Cumulative gain past year
| Period | CHRW Return | S&P 500 |
|---|---|---|
| 1m | -4.3% | -2.4% |
| 3m | -10.4% | -2.3% |
| 6m | -18.2% | +2.8% |
| 1y | -11.2% | +11.3% |
| ytd | -18.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHRW Fundamental Analysis
Revenue is growing robustly at the top line: Q3 2026 revenue of $5.358 billion rose 29.5% year-over-year versus $4.137 billion in Q3 2025, extending a clear sequential acceleration from $4.013 billion in Q1 and $4.934 billion in Q2. The transportation segment dominates at $5.012 billion of the $5.358 billion total, with sourcing contributing just $345.9 million, so the growth is almost entirely freight-driven — likely a mix of higher purchased-transportation costs passed through and share gains. Notably, this 29.5% revenue growth contrasts sharply with the stock's -15.4% one-year decline, implying the market is discounting the quality of that growth (cost pass-through versus margin-accretive volume) rather than celebrating it.
Profitability is solid and improving on a gross-profit basis: Q3 2026 net income reached $198.5 million (EPS $1.69) on gross profit of $808.4 million, a 15.1% gross margin that expanded from 14.96% in Q2 and 7.67% in Q1 (the Q1 figure reflects a reporting quirk where cost of revenue was classified differently). Net margin of 3.7% and operating margin of 5.1% are consistent with the thin-margin brokerage model, while the trailing twelve-month ROE of 31.8% and ROA of 10.3% are genuinely strong for a capital-light intermediary. The trend of rising gross profit dollars — $737.97 million in Q2 to $808.43 million in Q3 — alongside stable ~5% operating margins suggests pricing power and AI-driven SG&A leverage are offsetting purchased-transportation inflation.
Balance sheet and cash flow present the key concern: free cash flow TTM is $505.9 million, but quarterly FCF has been lumpy and weak — just $106.6 million in Q3, $30.9 million in Q2, and $66.0 million in Q1 — as working capital absorbed cash (Q3 change in working capital was -$136.9 million). Debt-to-equity of 0.88 and a current ratio of 1.53 indicate adequate but not fortress liquidity, and the company returned heavy capital via $207.7 million of buybacks and $74.8 million of dividends in Q3 alone, funded partly by drawing on cash. The 1.56% dividend yield with a 51.3% payout ratio is sustainable, but the combination of aggressive buybacks, working-capital drag, and modest quarterly FCF means CHRW has limited internal cushion if the freight cycle deteriorates further.
Quarterly Revenue
$5.4B
2026-09
Revenue YoY Growth
+29.5%
YoY Comparison
Gross Margin
15.1%
Latest Quarter
Free Cash Flow
$505868000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHRW Overvalued?
Because net income is positive ($198.5 million in Q3, TTM EPS positive), the PE ratio is the appropriate primary metric. The trailing PE of 32.9x stands in sharp contrast to the forward PE of 16.8x — a roughly 49% compression that implies the market expects earnings to nearly double, consistent with consensus EPS estimates of $7.96 for the forward period versus the current depressed trailing figure. That wide trailing-to-forward gap is the crux of the bull case: investors are being asked to pay a rich multiple on backward-looking earnings for a much cheaper multiple on expected recovery earnings.
Against the Integrated Freight & Logistics industry, the picture is mixed: the PS ratio of 1.19x and EV/Sales of 0.905x look inexpensive for a company with 29.5% revenue growth, but the EV/EBITDA of 23.4x and P/B of 10.5x are elevated, reflecting the capital-light model's high book-value multiple. The PEG ratio of 1.29 suggests the forward growth is reasonably priced relative to the multiple, while the 1.56% dividend yield is modest. On balance, CHRW trades at a premium on earnings-based and book-based measures but a discount on sales-based measures — a profile typical of a high-ROE, asset-light intermediary where book value understates earning power.
Historically, the stock's PE has ranged widely: it printed 21.9x at the Q3 2026 mark, 29.8x in Q2, 33.8x in Q1, and 35.3x at year-end 2025, versus a low of 9.4x in mid-2022 and 13.3x in Q3 2022 during the freight boom. The current trailing PE of 32.9x sits near the upper end of its recent band, while the PS ratio of 1.19x is well below the 3.2x-5.0x levels seen through 2025-2026 — a divergence that reflects the revenue surge diluting the sales multiple while earnings remain compressed. The market is thus pricing CHRW at a historically rich earnings multiple on trough profits, betting on margin recovery rather than offering a deep-value entry.
PE
32.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
32.4x
Industry PE ~32.4x*
EV/EBITDA
23.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash generation and capital allocation. Quarterly free cash flow has been lumpy and weak — $106.6 million in Q3, $30.9 million in Q2, and $66.0 million in Q1 — as working capital absorbed $136.9 million in Q3, while the company returned $207.7 million of buybacks and $74.8 million of dividends in the same quarter, partly funded by drawing on cash. Debt-to-equity of 0.88 and a current ratio of 1.53 indicate adequate but not fortress liquidity, and with net margin at 3.7% and operating margin at 5.1%, a modest volume decline would flow disproportionately to earnings. Revenue concentration compounds this: domestic freight brokerage is roughly 64% of net revenue and global forwarding 26%, so a single freight-cycle downturn hits the vast majority of the top line.
Market and competitive risks are dominated by valuation compression and disruption. The trailing PE of 32.9x sits near the upper end of its recent 21.9x-35.3x band on trough earnings, so any disappointment in the recovery path could compress the multiple toward the 9.4x-13.3x levels seen in 2022. Amazon's entry into third-party logistics — a $1.3 trillion TAM framed as an AWS-style playbook — threatens to commoditize the brokerage matching function that underpins CHRW's pricing power, while a beta of 0.947 offers little protection given the -40.5% max drawdown shows idiosyncratic freight and competitive risk dominate. The stock's -25.0% one-year relative strength gap versus the S&P 500 also exposes it to sector rotation out of cyclicals if freight recovery keeps getting pushed out.
The worst-case scenario is a chain in which Q4 volumes fail to stabilize, gross margin slips back below 15%, Amazon wins meaningful brokerage share, and analysts mark targets down toward the $131 low — with a decisive break below the $122.21 52-week low triggering stop-loss cascades and new lows. From the current $125.33, a move to the 52-week low represents roughly -2.5%, but a retest of the 2022-era valuation trough on trough earnings could imply a far deeper decline; the -40.5% max drawdown already realized shows losses of that magnitude are plausible. Realistically, an adverse scenario of -15% to -25% (toward $94-$107) is achievable if consensus EPS of $7.96 is revised down and the forward multiple compresses simultaneously.
FAQ
Ranked by severity, the first risk is competitive disruption: Amazon's entry into third-party logistics, framed as a $1.3 trillion TAM following an AWS-style playbook, directly threatens the domestic brokerage business that generates roughly 64% of net revenue, and commoditization of the matching function would erode the pricing power behind the 15.1% gross margin. Second is estimate and valuation risk: the stock trades below every published analyst target (low $131.00) with a target spread of roughly 79% of the current price, and the trailing PE of 32.9x sits near the top of its recent band, so any downward revision to the $7.96 consensus EPS would compress the multiple and the earnings base simultaneously. Third is financial and cash-flow risk: quarterly free cash flow has been lumpy and weak ($106.6 million in Q3, $30.9 million in Q2, $66.0 million in Q1) as working capital absorbed $136.9 million in Q3, while the company returned $207.7 million of buybacks and $74.8 million of dividends in the same quarter, leaving debt-to-equity at 0.88 and limited internal cushion. Fourth is macro and cyclical risk: with a beta of 0.947 offering little downside protection, a soft freight cycle or a sector rotation out of cyclicals — already visible in the -25.0% one-year relative strength gap versus the S&P 500 — could keep the stock pinned near its $122.21 low even if company execution improves.
The three-scenario framework assigns a 45% probability to the base case, a 30% to the bull case, and 25% to the bear case. The base case targets $131-$179 and assumes a slow, uneven freight recovery with volumes soft through early 2027, gross margin holding in the 14.5%-15.5% band, consensus EPS of $7.96 delivered without material revision, and the forward PE staying near 16.8x so returns come from earnings rather than multiple expansion. The bull case targets $179-$235 and requires Q4 gross margin above 15% with sequential volume stabilization, AI-driven SG&A leverage lifting operating margin from 5.1% toward 6%, a spot truckload rate recovery, and analyst targets revised back toward the $235 high. The bear case targets $94-$122 and is triggered by Q4 volumes failing to stabilize, gross margin slipping below 15%, Amazon winning meaningful brokerage share, and a decisive break of the $122.21 low that triggers stop-loss cascades. The base case is most likely at 45%, and its key assumption is that the $7.96 consensus EPS is broadly achieved without material downward revision — the single variable that determines whether the 16.8x forward multiple is a bargain or a trap.
The answer depends entirely on which earnings base you use. On trailing figures CHRW looks expensive: the PE of 32.9x sits near the top of its recent 21.9x-35.3x band, P/B is 10.5x, EV/EBITDA is 23.4x, and the price-to-cash-flow ratio is 21.1x — all rich for a 3.7% net-margin broker. On forward figures it looks far more reasonable: the PE compresses to 16.8x on consensus EPS of $7.96, the PEG of 1.29 suggests growth is fairly priced, and PS of 1.19x and EV/Sales of 0.905x are cheap against 29.5% revenue growth, though that growth is largely purchased-transportation pass-through. Historically, the PS multiple of 1.19x is well below the 3.2x-5.0x levels seen through 2025-2026, while the trailing PE sits near its recent high — a divergence that shows the market is paying up on trough earnings for a recovery it expects but has not yet seen. The verdict is fairly valued to modestly undervalued on forward earnings and expensive on trailing and book measures, meaning the market is pricing in roughly 49% EPS growth; if that $7.96 estimate is delivered the stock is cheap, and if it is cut the current price is not a discount at all.
From a pure risk/reward standpoint the setup is asymmetric but unconfirmed: the $179.30 average analyst target implies 43% upside, and even the lowest published target of $131.00 sits 4.5% above the $125.33 price, while the downside to the $122.21 52-week low is only about 2.5% — but a break there could extend losses toward the $94-$107 zone, or roughly -15% to -25%. The fundamental case is credible, with 15.1% gross margin, 31.8% ROE, and a forward PE of 16.8x versus 32.9x trailing on $7.96 consensus EPS, yet the stock is in a confirmed downtrend with a -40.5% max drawdown and -25.0% one-year relative underperformance. The biggest downside risk is that Amazon's 3PL push commoditizes the ~64%-of-revenue brokerage franchise while estimates are still catching down, which is why the stock trades below every published target. It is a reasonable buy for patient, risk-tolerant investors who can accumulate in tranches and wait 12-24 months for a freight recovery, but momentum-sensitive or short-horizon buyers should wait for a reclaim of the $157-$160 breakdown zone or a gross-margin confirmation above 15% before committing.
CHRW is better suited to a long-term hold than to short-term trading, though position sizing must respect its cyclicality. The company is a mature, capital-light intermediary with 11,855 employees, a 1.56% dividend yield backed by a sustainable 51.3% payout ratio, and a 31.8% ROE — characteristics that favor patient ownership through a freight cycle rather than tactical trading. Short-term traders face a hostile tape: the stock is down 7.3% in one month, 16.1% in three months, and 26.9% in six months, sits 1.6% above its 52-week low, and carries gap risk around earnings, as the July 23-to-July 30 slide from $205.51 to $146.92 demonstrated. Earnings visibility is also limited, with quarterly FCF ranging from $30.9 million to $106.6 million and a 79%-of-price analyst target spread signaling genuine disagreement on recovery timing. A concrete minimum holding period of 12-24 months is appropriate, allowing time for the Q4 2026 and 2027 prints to confirm whether gross margin holds above 15% and volumes stabilize; investors should accumulate in tranches rather than in a single entry, and reassess if the stock breaks below $122.21 or gross margin falls under 14.5%.

